Front-line lenalidomide therapy in patients with newly diagnosed multiple myeloma.

about

Front-line lenalidomide therapy in patients with newly diagnosed multiple myeloma.

Item

http://www.wikidata.org/entity/Q38413040

description

2015 nî lūn-bûn

@nan

2015年の論文

@ja

2015年論文

@yue

2015年論文

@zh-hant

2015年論文

@zh-hk

2015年論文

@zh-mo

2015年論文

@zh-tw

2015年论文

@wuu

2015年论文

@zh

2015年论文

@zh-cn

name

Front-line lenalidomide therapy in patients with newly diagnosed multiple myeloma.

@en

type

Item

label

Front-line lenalidomide therapy in patients with newly diagnosed multiple myeloma.

@en

prefLabel

Front-line lenalidomide therapy in patients with newly diagnosed multiple myeloma.

@en

P1476

Front-line lenalidomide therapy in patients with newly diagnosed multiple myeloma

@en

P2093

María J Cejalvo

http://www.w3.org/2001/XMLSchema#string

P2860

Biological activity of lenalidomide and its underlying therapeutic effects in multiple myeloma

Cereblon is a direct protein target for immunomodulatory and antiproliferative activities of lenalidomide and pomalidomide

Multiple myeloma

The myeloma drug lenalidomide promotes the cereblon-dependent destruction of Ikaros proteins

Lenalidomide causes selective degradation of IKZF1 and IKZF3 in multiple myeloma cells

Impact of high-risk classification by FISH: an eastern cooperative oncology group (ECOG) study E4A03.

Lenalidomide plus high-dose dexamethasone versus lenalidomide plus low-dose dexamethasone as initial therapy for newly diagnosed multiple myeloma: an open-label randomised controlled trial

Second primary malignancies with lenalidomide therapy for newly diagnosed myeloma: a meta-analysis of individual patient data.

Immunomodulatory drug CC-5013 overcomes drug resistance and is well tolerated in patients with relapsed multiple myeloma.

Lenalidomide-induced myelosuppression is associated with renal dysfunction: adverse events evaluation of treatment-naïve patients undergoing front-line lenalidomide and dexamethasone therapy.

P304

1643-1658

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.2217/FON.15.51

http://www.w3.org/2001/XMLSchema#string

P407

English

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Javier de la Rubia

P577

2015-04-10T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

25857329

http://www.w3.org/2001/XMLSchema#string